Susceptibility of 228 Non-fermenting Gram-Negative Rods to Tigecycline and Six Other Antimicrobial Drugs

REFERENCES

• Ferrara AM. Potentially multidrug-resistant non-fermenta-tive Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents. 2006; 27 (3): 183–95.
   PubMed Web of Science ®Google Scholar
• Jones RN. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir Crit Care Med. 2003;24 (1): 121–34.
   PubMed Web of Science ®Google Scholar
• Schreckberger PC, Daneshvar MI, Weyant RS, Hollis DG. Achromobacter, Chryseobacterium, Moraxella, and other non-fementative gram-negative rods. In: Murray PR, Baron EJ, Jor-gensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology. 8 ed. Washington, DC: ASM Press 2003: 749-79.
   Google Scholar
• Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother. 1999; 43 (4): 738–44.
   PubMed Web of Science ®Google Scholar
• Fluit AC, Florijn A, Verhoef J, Milatovic D. Presence of tetracycline resistance determinants and susceptibility to tigecy-cline and minocycline. Antimicrob Agents Chemother. 2005;49 (4): 1636–8.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Tigecycline: what is it, and where should it be used? J Antimicrob Chemother. 2005; 56 (4): 611–4.
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Suscepti-bility Testing; Eighteenth Informational Supplement. CLSI doc-ument M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute 2008.
   Google Scholar
• Hohl P, Frei R, Aubry P. In vitro susceptibility of 33 clini-cal case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results. Diagn Microbiol Infect Dis. 1991; 14 (5): 447–50.
   PubMed Web of Science ®Google Scholar
• Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol. 2001; 39 (1): 183–90.
   PubMed Web of Science ®Google Scholar
• Pankuch GA, Jacobs MR, Rittenhouse SF, Appelbaum PC. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase in-hibitor combinations) and ciprofloxacin tested by five methods. Antimicrob Agents Chemother. 1994; 38 (10): 2317–22.
   PubMed Web of Science ®Google Scholar
• Arpi M, Victor MA, Mortensen I, Gottschau A, Bruun B. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion meth-ods. Apmis. 1996; 104 (2): 108–14.
   PubMed Web of Science ®Google Scholar
• Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemio-logical features. Clin Microbiol Rev. 1996; 9 (2): 148–65.
   PubMed Web of Science ®Google Scholar
• Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005; 11 (11): 868–73.
   PubMed Web of Science ®Google Scholar
• Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis. 2000; 31 (1): 101–6.
   PubMed Web of Science ®Google Scholar
• Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect. 2005; 11 (2): 115–21.
   PubMed Web of Science ®Google Scholar
• Betriu C, Rodriguez-Avial I, Sanchez BA, Gomez M, Al-varez J, Picazo JJ. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob Agents Chemother. 2002; 46 (3): 892–5.
   PubMed Web of Science ®Google Scholar
• Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and noso-comial pneumonia. Diagn Microbiol Infect Dis. 2005; 52 (3): 187–93.
   PubMed Web of Science ®Google Scholar
• Akova M, Bonfiglio G, Livermore DM. Susceptibility to beta-lactam antibiotics of mutant strains of Xanthomonas mal-tophilia with high- and low-level constitutive expression of Li and L2 beta-lactamases. J Med Microbiol. 1991; 35 (4): 208–13.
   PubMed Web of Science ®Google Scholar
• Yao JD, Louie M, Louie L, Goodfellow J, Simor AE. Com-parison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia. J Clin Microbiol. 1995; 33 (5): 1428–30.
   PubMed Web of Science ®Google Scholar
• Garcia-Rodriguez JA, Garcia Sanchez JE, Garcia Garcia MI, Garcia Sanchez E, Munoz Bellido JL. Antibiotic susceptibil-ity profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations. Diagn Microbiol Infect Dis. 1991; 14 (3): 239–43.
   PubMed Web of Science ®Google Scholar
• Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas mal- tophilia to antimicrobial agents: implications for therapy. An-timicrob Agents Chemother. 1994; 38 (3): 624–7.
   PubMed Web of Science ®Google Scholar
• Dean CR, Visalli MA, Projan SJ, Sum PE, Bradford PA. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PA01. Antimicrob Agents Chemother. 2003; 47 (3): 972–8.
   PubMed Web of Science ®Google Scholar
• Sanchez-Romero I, Cercenado E, Cuevas O, Garcia-Es-cribano N, Garcia-Martinez J, Souza E. Evolution of the antimi-crobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003). Rev Esp Quimioter. 2007; 20 (2): 222–9.
   PubMed Web of Science ®Google Scholar